CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 60 enrolled
Drug / intervention
Ropivacaine Continuous Infusion +2 moredrug
Likely dose
Ropivacaine Continuous Infusion 6mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05053087
NCT05053087Phase 3Completed
CompareCT.gov

A Three-Arm, Double-Blinded, Randomized Controlled Trial Comparing the Efficacy of Adductor Canal Pain Catheters Following Total Knee Arthroplasty

Mayo Clinic·interventional·Posted Sep 22, 2021·Updated Feb 22, 2024

In Brief

A Phase 3 clinical trial evaluating Ropivacaine Continuous Infusion, Ropivacaine Intermittent Bolus, and 1 other intervention for Osteoarthritis, Knee. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The purpose of this research is to study how well the adductor canal pain catheters works after a total knee arthroplasty or replacement of the knee joint. The catheter works by using either an intermittent bolus injection to provide a large dose of medication or continuous infusion of pain medicine, ropivacaine 0.2%, compared to a single-shot adductor canal block.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20222023202420252026
First PostedSep 22, 2021
Enrollment StartApr 13, 2022
Primary CompletionFeb 27, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.8 years ago

Interventions

Ropivacaine Continuous Infusiondrug

0.2% continuous infusion 6mL/hr

Ropivacaine Intermittent Bolusdrug

0.2% intermittent bolus infusion 8mL every 2 hours

Placebodrug

Saline filled catheter